Reven Pharmaceuticals Reports Positive Results Regarding the Clinical Safety and Preclinical Efficacy of its COVID-19 Drug Candidate Rejuveinix (RJX)

Reven today announced the publication of a peer-reviewed article in the prestigious medical journal, Frontiers in Pharmacology, Section: Respiratory Pharmacology. In this new publication, the Reven Pharmaceuticals team reports positive results regarding the clinical safety and preclinical efficacy … Read More The post Reven Pharmaceuticals Reports Positive Results Regarding the Clinical Safety and Preclinical Efficacy of its COVID-19 Drug Candidate Rejuveinix (RJX) appeared first on Reven Pharmaceuticals .